Navigation Links
Louisiana Department of Health and Hospitals Announces Intent to Award Cost Containment Services Contract to HMS
Date:7/14/2008

NEW YORK, July 14 /PRNewswire/ -- The Louisiana Department of Health and Hospitals announced its intent to award HMS a contract to continue providing Third Party Liability (TPL) recovery and cost avoidance services to the state's Medicaid program. This statement of intent is the result of HMS having achieved the highest score in a competitive procurement process for the three-year contract.

During its most recent contract with the state, HMS recovered more than $36 million for the Department.

"Our decision to award this contract to HMS demonstrates our agency's continued trust in HMS's expertise and resources in revenue recovery and cost avoidance solutions," said William Perkins, TPL Director of the Department of Health and Hospitals. "Clearly their results speak for themselves and we look forward to even greater accomplishments."

HMS's President, Bill Lucia, believes that the long-term relationship with Louisiana is critical to building the expertise required to continually develop new and innovative processes and technologies. "Under the current economic constraints, no effort can be spared in the search for every recoverable dollar and every avoidable expense," he explained.

About HMS

HMS is the nation's leader in cost containment, coordination of benefits, and program integrity services for government healthcare programs. HMS serves the Medicaid programs of 37 states and 80 Medicaid managed care plans. In addition, the company provides services to CMS, child support agencies, SCHIP, and Veterans Administration facilities. In 2007 alone, HMS recovered more than $1 billion from third parties and other funding sources for its clients, and provided data that assisted them in saving billions of dollars more. HMS is a wholly owned subsidiary of HMS Holdings Corp. (Nasdaq:

SOURCE HMS
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Louisiana Improves Law for Treating Mentally Ill
2. CRH Medical Corporation opens center in New Orleans, Louisiana
3. Louisiana May Mandate Fluoridation Despite Evidence of Harm
4. Asbestos Verdict Upheld by Louisiana Court of Appeal, Announces Baron & Budd
5. Hospitals in Louisiana and Mississippi to Receive More Katrina Recovery Grants
6. Louisiana Advisor to Speak Nationwide
7. Bright Options for Medicare Beneficiaries in Louisiana
8. Louisiana Tech professor is Small Times Innovator of the Year
9. Justice Department Reaches Settlement Agreement With Medical Weight Loss Clinic
10. Its the Same Old Song: Accentuate the Positive as New York State Department of Health Releases Statewide Hospital Infection Rates
11. Anthem Blue Cross Statement on Settlement Discussions with the California Department of Managed Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2Health News:Help Young Cancer Patients Enjoy Christmas This Season 2
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 1The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 2Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 1Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 2Mike Fuljenz and Universal Coin 26amp 3B Bullion Sponsors the NRA Eddie Eagle GunSafe Program 14381 1Mike Fuljenz and Universal Coin 26amp 3B Bullion Sponsors the NRA Eddie Eagle GunSafe Program 14381 2